Please login to the form below

Not currently logged in
Email:
Password:

Gyros Protein Technologies appoints Asia-Pacific VP

Peter Luk tasked with driving the company’s expansion in the region

Gyros Protein Technologies Peter LukGyros Protein Technologies has appointed Peter Luk as vice president, Asia-Pacific to begin its planned expansion in the region.

Luk brings over 25 years of life science business experience in Asia to the recently-formed Swedish biopharmaceutical company.

He joins from ProteinSimple, where he served as its general manager for the Asia region, and prior to this was vice president, Asia-Pacific at Molecular Devices, a bioanalytical research solutions company.

Luk has also held management roles in the Asia divisions at Bio-Rad Laboratories, Packard BioSciences and PerkinElmer.

Dan Calvo, CEO of Gyros Protein Technologies, said: “We are delighted to welcome Peter to the Gyros Protein Technologies team.

“With Peter's many years of experience and exceptional track record in building high value life science businesses in the Asia-Pacific market, we are confident he will be an invaluable asset as the company expands in the region.”

27th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics